Community Support Program for Lung Cancer Screening Volume II

NCT06628167 | Completed Results

• 1 other identifier: 08524
• Study Type: interventional
• Target: 252
• Locations: 1 country
• Sites: 1

Brief Summary

This is a West Philadelphia based community project to improve adherence to lung cancer screening. The overall objective of this project is to demonstrate the impact of a community support program (CSP) on improve adherence to LCS follow-up guidelines in an urban environment. The study will target individuals in the Penn Medicine healthcare system residing in Philadelphia with an upcoming or missed follow-up screening or orders placed but who have not yet scheduled their screenings by offering free transportation coordination to and from the appointment. The study team will also offer to connect those with placed but unscheduled low dose CT orders to connect with Penn Medicine's scheduling staff.

Conditions

Lung Cancer

Outcome Measures

Primary Outcomes (1)

• Scheduled Lung Cancer Screening Appointments Attended by Participants

  The Primary Outcome measures appointment attendance across three groups: West Philadelphia CSP Participants (eligible West Philadelphia residents who opted into the CSP), West Philadelphia Non CSP Participants (eligible West Philadelphia residents who did not opt into the CSP), and Southwest Philadelphia Residents (patients who did not receive an option to participate in the CSP).

  12 months

Secondary Outcomes (1)

• CSP Enrollment

  12 months

Study Arms (2)

West Philadelphia

EXPERIMENTAL

Eligible patient population lives in West Philadelphia

Behavioral: Transportation; Behavioral: Scheduling

Southwest Philadelphia

NO INTERVENTION

Eligible patient population lives in Southwest Philadelphia

Interventions

Transportation BEHAVIORAL

Participants with ordered low dose CT and participants with scheduled low dose CT are offered free transportation to and from appointment. Participants with ordered low dose CT are also offered assistance in connecting with scheduling staff.

West Philadelphia

Scheduling BEHAVIORAL

Participants with ordered low dose CT are offered assistance in connecting with scheduling staff.

West Philadelphia

Eligibility Criteria

• Age: 18 Years - 89 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Upcoming or missed low dose CT for lung cancer screening
• Philadelphia resident

You may not qualify if:

• Lives outside Philadelphia city limits

Sponsors & Collaborators

• University of Pennsylvania: collaborator
• Abramson Cancer Center at Penn Medicine: lead

Study Sites (1)

Univeristy of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Lung Neoplasms

Interventions

Transportation; Appointments and Schedules

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Technology, Industry, and Agriculture; Organization and Administration; Health Services Administration

Results Point of Contact

• Title: Dr. Farouk Dako
• Organization: University of Pennsylvania

farouk.dako@pennmedicine.upenn.edu

2673091241

Study Officials

• Farouk Dako, MD

  farouk.dako@pennmedicine.upenn.edu

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 26, 2024
• First Posted: October 4, 2024
• Study Start: October 1, 2024
• Primary Completion: February 1, 2026
• Study Completion: February 1, 2026
• Last Updated: March 24, 2026
• Results First Posted: March 24, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)